Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes

Abstract

Fondaparinux is similar to enoxaparin in reducing the risk of ischemic events at nine days, but it substantially reduces major bleeding and improves long term mortality and morbidity. (ClinicalTrials.gov number, NCT00139815.).

Keywords

FondaparinuxMedicineAcute coronary syndromeHeparinCardiologyAnticoagulantInternal medicineEnoxaparin sodiumLow molecular weight heparinMyocardial infarctionThrombosisVenous thromboembolism

Related Publications

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Stephen D. Wiviott , Eugene Braunwald , Carolyn H. McCabe +11 more

In patients with acute coronary syndromes with scheduled percutaneous coronary intervention, prasugrel therapy was associated with significantly reduced rates of ischemic events...

2007 New England Journal of Medicine 6636 citations

Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction

Tatjana Potpara

When administered with heparin and aspirin, the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban was associated with a lower incidence of ischemic events in patients ...

1998 New England Journal of Medicine 1320 citations

Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm

Jean‐Pierre Bassand

Over the last two decades, major improvements in clinical outcome have been achieved in the management of acute coronary syndromes (ACS), with or without ST-segment elevation. I...

2007 European Heart Journal 364 citations

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

Renato D. Lópes , Gretchen Heizer , Ronald Aronson +19 more

In patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y<sub>12</sub> inhibitor, an antithrombotic regimen that included apixaban, wit...

2019 New England Journal of Medicine 1106 citations

Bivalirudin during Primary PCI in Acute Myocardial Infarction

Gregg W. Stone , Bernhard Witzenbichler , Giulio Guagliumi +12 more

In patients with ST-segment elevation myocardial infarction who are undergoing primary PCI, anticoagulation with bivalirudin alone, as compared with heparin plus glycoprotein II...

2008 New England Journal of Medicine 1836 citations

Publication Info

Year: 2006
Type: article
Volume: 354
Issue: 14
Pages: 1464-1476
Citations: 1224
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1224

OpenAlex

Cite This

APA Style

                            
                                
                                    Salim Yusuf, 
                                
                                    Shamir R Mehta, 
                                
                                    Susan Chrolavicius
                                
                                et al.
                            
                            (2006). 
                            Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes. 
                            New England Journal of Medicine
                            , 354
                            (14)
                            , 1464-1476.
                            https://doi.org/10.1056/nejmoa055443
                        

Identifiers

DOI: 10.1056/nejmoa055443